Skip to main content
International Journal of Experimental Diabetes Research logoLink to International Journal of Experimental Diabetes Research
. 2002;3(4):241–245. doi: 10.1080/15604280214936

C-Peptide Prevents Hippocampal Apoptosis in Type 1 Diabetes

Zhen-guo Li 1,3, Weixian Zhang 1,3, Anders A F Sima 1,2,3,4,
PMCID: PMC2478591  PMID: 12546277

Abstract

To explore mechanisms underlying central nervous system (CNS) complications in diabetes, we examined hippocampal neuronal apoptosis and loss, and the effect of C-peptide replacement in type 1 diabetic BB/W rats. Apoptosis was demonstrated after 8 months of diabetes, by DNA fragmentation, increased number of apoptotic cells, and an elevated ratio of Bax/Bcl-xL, accompanied by reduced neuronal density in the hippocampus. No apoptotic activity was detected and neuronal density was unchanged in 2-month diabetic hippocampus, whereas insulin-like growth factor (IGF) activities were impaired. In type 1 diabetic BB/W rats replaced with C-peptide, no TdT-mediated dUTP nick-end labeling (TUNEL)- positive cells were shown and DNA laddering was not evident in hippocampus at either 2 or 8 months. C-peptide administration prevented the preceding perturbation of IGF expression and reduced the elevated ratio of Bax/Bcl-xL. Our data suggest that type 1 diabetes causes a duration-dependent programmed cell death of the hippocampus, which is partially prevented by C-peptide.

Full Text

The Full Text of this article is available as a PDF (151.6 KB).


Articles from International journal of experimental diabetes research are provided here courtesy of Wiley

RESOURCES